COVID-19: Considerations for Child Psychiatric Trials Date Published: May 05, 2020 Whitepaper This informational white paper is part of a compendium intended to share best practices and ongoing learnings related to the impact of COVID-19 on ongoing and planned clinical trials. Content is authored by a dedicated team of experienced scientists, clinicians, technologists, and data quality experts. Download Now Share: LinkedInTweet